Titan Pharmaceuticals (NASDAQ: TTNP) Announces Asset Purchase Agreement With JT Pharmaceuticals
Titan Pharmaceuticals (NASDAQ: TTNP) shares soared 28.71% during the pre-market trading session of Tuesday after the company announced that it has signed an Asset Purchase Agreement with JT Pharmaceuticals, Inc. Titan Pharmaceuticals revealed that it has bought the kappa opioid agonist peptide, JT-09 of JT Pharmaceuticals, for use in combination with Titan’s ProNeura long-term, continuous drug […]